DK0803502T3 - Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater - Google Patents

Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater

Info

Publication number
DK0803502T3
DK0803502T3 DK97106476T DK97106476T DK0803502T3 DK 0803502 T3 DK0803502 T3 DK 0803502T3 DK 97106476 T DK97106476 T DK 97106476T DK 97106476 T DK97106476 T DK 97106476T DK 0803502 T3 DK0803502 T3 DK 0803502T3
Authority
DK
Denmark
Prior art keywords
optically active
preparation
carboxylic acid
acid derivatives
piperazine carboxylic
Prior art date
Application number
DK97106476T
Other languages
English (en)
Inventor
Rudolf Dr Fuchs
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Application granted granted Critical
Publication of DK0803502T3 publication Critical patent/DK0803502T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
DK97106476T 1996-04-23 1997-04-18 Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater DK0803502T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH102896 1996-04-23

Publications (1)

Publication Number Publication Date
DK0803502T3 true DK0803502T3 (da) 2002-09-23

Family

ID=4200769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97106476T DK0803502T3 (da) 1996-04-23 1997-04-18 Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater

Country Status (9)

Country Link
US (1) US5945534A (da)
EP (1) EP0803502B1 (da)
JP (1) JP4138906B2 (da)
AT (1) ATE219769T1 (da)
CA (1) CA2201218C (da)
DE (1) DE59707584D1 (da)
DK (1) DK0803502T3 (da)
ES (1) ES2179238T3 (da)
PT (1) PT803502E (da)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011995A (en) * 1987-07-28 1991-04-30 Ciba-Geigy Corporation Process for the preparation of optically active secondary amines
US4996361A (en) * 1987-07-30 1991-02-26 The University Of British Columbia Process for the preparation of optically active secondary arylamines
ATE163926T1 (de) * 1991-11-08 1998-03-15 Merck & Co Inc Hiv-protease-inhibitoren verwendbar in der aids- behandlung
EP0564406B1 (de) * 1992-04-02 1999-05-06 Novartis AG Ferrocenyldiphosphine als Liganden für homogene Katalysatoren
DE59410267D1 (de) * 1993-02-26 2003-05-15 Syngenta Participations Ag Ferrocenyldiphosphine als Liganden für homogene Katalysatoren
US5353193A (en) * 1993-02-26 1994-10-04 Lsi Logic Corporation High power dissipating packages with matched heatspreader heatsink assemblies
JP3547136B2 (ja) * 1993-07-16 2004-07-28 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤の製造方法
IL110255A (en) * 1993-07-16 1998-12-06 Merck & Co Inc Creation and resolution of 2 tert-butylcarboxamidopiprazine
US5734055A (en) * 1993-11-22 1998-03-31 Koei Chemical Co. Ltd. Process for preparing N-tert-butyl-2-pyrazinecarboxamide and N-tert-butyl-2-piperazinecarboxamide
TW472047B (en) * 1994-02-04 2002-01-11 Merck & Co Inc Process for making HIV protease inhibitors
JPH07291943A (ja) * 1994-04-22 1995-11-07 Koei Chem Co Ltd 光学活性Ｎ−ｔｅｒｔ−ブチル−２−ピペラジンカルボキサミドを製造する方法
US5612484A (en) * 1995-05-18 1997-03-18 Merck & Co., Inc. Process for making HIV protease inhibitors
ATE209190T1 (de) * 1995-05-23 2001-12-15 Lonza Ag Verfahren zur herstellung von optisch aktiven 2- piperazincarbonsäurederivaten
GB2302690A (en) * 1995-06-28 1997-01-29 Merck & Co Inc Process for preparing chiral 1,4-diacyl-(S)-piperazine-2-carboxamides using a diene/chiral bisphosphine/rhodium or iridium hydrogenation catalyst
US5723615A (en) * 1995-06-28 1998-03-03 Merck & Co., Inc. Process for preparing 4-tert-butyloxycarbonyl-(S)-piperazine-2-tert-butylcarboxamide

Also Published As

Publication number Publication date
JPH1045726A (ja) 1998-02-17
EP0803502B1 (de) 2002-06-26
ES2179238T3 (es) 2003-01-16
CA2201218A1 (en) 1997-10-23
DE59707584D1 (de) 2002-08-01
US5945534A (en) 1999-08-31
JP4138906B2 (ja) 2008-08-27
ATE219769T1 (de) 2002-07-15
EP0803502A3 (de) 1997-11-19
PT803502E (pt) 2002-11-29
CA2201218C (en) 2004-09-28
EP0803502A2 (de) 1997-10-29

Similar Documents

Publication Publication Date Title
IL125378A0 (en) Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
TR199501253A2 (tr) Amino(tio) eter türevleri.
ATE184194T1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)- homoserinlacton
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
DK0882725T3 (da) Quinoloncarboxylsyrederivater eller deres salte
PT845464E (pt) Compostos de estr 2-(hidroxi substituido)-2-indolidinilbutirico tipo s como intermediarios para derivados camptotecina
DK0791007T3 (da) Antifungale sordaridinderivater
DK0789019T3 (da) Fremgangsmåde til fremstilling af oxoimidazoliniumsalte
DK0626961T3 (da) Fremgangsmåde til nitrosering
DK0803502T3 (da) Fremgangsmåde til fremstilling af optisk aktive 2-piperazincarboxylsyrederivater
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
PL352172A1 (en) Derivatives of n-alkoxyalkylo-n,n-dialkyloamine or salts thereof and the agents containing these compounds used in treatment of neurodegenerative diseases
ATE44745T1 (de) Pyrimido(2,1-b)benzothiazolderivate und ihre salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen.
ATE199902T1 (de) N-benzylpiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
BR9712279A (pt) Composto intermediário de depsipeptídeo e processo para produzir um derivado de depsipeptídeo
TW346483B (en) Benzene derivatives
ATE325793T1 (de) Benzyliden-gamma-butyrolactone, verfahren zu ihrer herstellung und ihre verwendung als uv- absorber
DE59606328D1 (de) Verfahren zur Herstellung von gegebenenfalls 2-substituierten 5-Chlor-imidazol-4-carbaldehyden
AR006754A1 (es) Derivados de quinoxalina utiles en terapia
DE59814233D1 (de) Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
ATE107296T1 (de) Optisch aktive piperazin-derivate.
ATE204582T1 (de) Von neurokininen abgeleitete pseudopeptide, verfahren für ihre herstellung und sie enthaltende pharmazeutische zubereitungen